Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Veterinary Vaccines Market 2015-2022 - Companion Animal Vaccines and Livestock Vaccines - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

28 Jun, 2016, 18:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, June 28, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Veterinary Vaccines - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines).

The report profiles 102 companies including many key and niche players such as

  • Bayer HealthCare AG (Germany)
  • Biogénesis Bagó (Argentina)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Elanco Animal Health (US)
  • Heska Corporation (US)
  • Indian Immunologicals Ltd. (India)
  • Merck Animal Health (US)
  • Merial Ltd. (US)
  • Virbac SA (France)
  • Zoetis Inc. (US)

Key Topics Covered:

1. INDUSTRY OVERVIEW

  • Market Outlook
  • Convergence of Factors Prime the Market for Sizable Growth
  • Sizing the Global Veterinary Vaccines Market
  • Mature Markets Vis-a-vis Emerging Markets
  • Veterinary Vaccines
  • A Highly Consolidated Market
  • Scientific R&D
  • Crucial for Market Growth
  • Market Challenges

2. MARKET TRENDS & ISSUES

  • Need to Ensure Sustainable Food Supply Spurs Growth
  • Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
  • Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine
  • Management of Emerging Diseases
  • A Case of Development and Demand Novel Vaccines
  • Need to Safeguard Public Health Drives Interest in Veterinary Vaccines
  • Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines
  • Companion Animals: A Lucrative Market Segment
  • Increasing Pet Ownership Drives Demand for Companion Animal Vaccines
  • Spread of Zoonotic Diseases Propels Growth
  • Porcine Market Offers Significant Prospects for Growth and New Vaccine Development
  • Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccines
  • Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries
  • Recombinant DNA Technology to Take Over the Industry
  • Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems
  • New Effervescent Tablets Vaccines against NDV
  • Augmenting Trend towards Convenient Administration
  • One-Shot Vaccine against BVD
  • New Innovation Promises to Change Vaccination Paradigm
  • Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in the Pipeline
  • Global Efforts to Conquer FMD by an Effective Vaccine
  • Developments in the Poultry Vaccine Market
  • Vaccination
  • Critical for Controlling Avian Influenza Virus
  • Parasitic Vaccines Segment Holds Potential
  • Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
  • New Vaccines Strains
  • The Imminent Need in the Vaccine Market
  • The Need for Innovative Vaccine Delivery Mechanism Increasing
  • More Vaccines Needed to Prevent Zoonotic Infections
  • Plant-based Vaccines
  • the Next Avenue in Cost-effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut
  • Pricing Affects the Livestock Vaccine Market
  • Over-Vaccination Trend May Prove Harmful

3. PRODUCT OVERVIEW

  • Vaccines
  • An Evolutionary Scan
  • Veterinary Medicines
  • A Brief Review
  • Concept Development
  • Production of Vaccines
  • Veterinary Vaccines
  • An Essential Component of Animal Healthcare
  • What Does A Veterinary Vaccine Do?
  • Classification of Veterinary Vaccines
  • Companion Animal Vaccines
  • Canine Vaccines
  • Canine Distemper
  • Canine Parvovirus
  • Tracheobronchitis
  • Canine Coronavirus
  • Canine Leptospirosis
  • Canine Giardia
  • Canine Lyme borreliosis
  • Canine Rabies
  • Feline Vaccines
  • Feline Panleukopenia Virus Vaccine
  • Feline Calicivirus & Herpesvirus Vaccine
  • Rabies Virus Vaccine
  • Feline Leukemia Virus Vaccine
  • Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines
  • Livestock Vaccines
  • Bovine Vaccines
  • Bovine virus diarrhoea
  • Mucosal disease (BVD-MD)
  • Johne's disease
  • Infectious Bovine Rhinotracheitis (IBR)
  • Blackleg
  • Neosporosis
  • Poultry Vaccines
  • Ovine Vaccines
  • Porcine Vaccines
  • Equine Vaccines
  • Aquaculture Vaccines
  • A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
  • Vaccination and Its Reactions
  • Veterinary Vaccines
  • Latest Breakthroughs
  • Marker/DIVA Vaccines
  • DNA Vaccines
  • Gene-Deleted Vaccines
  • Viral-Vectored Vaccines

4. NOTES ON SELECT ANIMAL DISEASES

  • Brucellosis
  • Tuberculosis
  • Johne's disease
  • Spirochete Associated Diseases
  • Respiratory Disease in Goats, Sheep, and Cattle
  • Porcine Respiratory Diseases
  • Mastitis
  • African Swine Fever
  • Avian Influenza
  • East Coast Fever
  • Hemorrhagic Septicemia
  • Foot-And-Mouth Disease
  • Japanese Encephalitis
  • Rift Valley Fever
  • Equine Virus Infection

5. PRODUCT LAUNCHES AND INNOVATIONS

  • MSD Animal Health Unveils PORCILIS PCV ID
  • Virbac Rolls Out Lepto4 Vaccine
  • Merck Animal Health Rolls Introduces Vaccine against New H3N2 Strain
  • Zoetis Launches First USDA-Approved Equine Leptospirosis Vaccine, Lepto EQ
  • Ceva Introduces New Porcine Pneumonia Vaccine
  • Boehringer Ingelheim Rolls Out Two New PRRS Swine Vaccines in Europe
  • MSD Animal Health Launches INNOVAX®-ILT
  • Zoetis UK Unveils New Versican® Plus Canine Vaccine Range
  • Indian Immunologicals to Launch Procine Cysticercosis Vaccine
  • MSD Animal Health Rolls Out Single-Injection Vaccine for Salmon
  • Merck Animal Health Launches PORCILIS® PCV M Hyo Single- Injection Vaccine for Piglets
  • Prevtec Microbia Obtains EU Clearance for Coliprotec F4 Vaccine
  • Hester Biosciences Rolls Out Two New Vaccines
  • Boehringer Ingelheim Vetmedica Launches Bovela® BVD Vaccine
  • Immunologicals Launches First Vaccine against Bluetongue Disease in India
  • Boehringer Ingelheim Secures EU Clearance for BVD Vaccine Bovela®
  • Merck Animal Health Rolls Out PRIME PAC PRRS+ Porcine Vaccine
  • Larad to Sell Poultry IBD Vaccine
  • AgriLabs Introduces Autogenous Klebsiella Mastitis Vaccine
  • Boehringer Ingelheim Vetmedica Introduces ULTRA Fel-O-Vax® Vaccine for Cats
  • Boehringer Ingelheim Vetmedica Introduces New Vaccine for Respiratory Diseases in Pigs
  • Valneva Launches Second Vaccine in EB66® Cell Line in South America
  • Merck Animal Health Launches Combination Vaccine with Longer Immunity Duration for Pigs

6. RECENT INDUSTRY ACTIVITY

  • Bayer Teams Up with BioNTech for Development of Innovative Veterinary mRNA Vaccines
  • Harrisvaccines Secures Production Platform Vaccine Licensure from USDA
  • Orix to Acquire Kyoto Biken
  • Phibro to Take Over Vaccine Assets of MVP Laboratories
  • Sumitomo Acquires Stake in Shandong Sinder Technology
  • Sanofi and Boehringer Ingelheim Ink Deal to Swap Business
  • Merck Animal Health Inks Deal to Take Over Harrisvaccines
  • Zoetis to Take Over PHARMAQ
  • VitamFero and Bioproperties Execute Co-development and Distribution Deal for Toxoplasmosis Vaccine
  • Dechra to Buy Chicken Vaccine Maker Genera
  • Valneva Licenses EB66(r) Cell Line for Vaccines to Jianshun Biosciences for China
  • Eli Lilly Acquires Novartis Animal Health through Elanco
  • Biogénesis Bagó Begins Construction of New Vaccine Plant in China
  • Inovio Pharmaceuticals's Subsidiary Divests Animal Health Assets
  • Braasch Biotech Receives Patent Acceptance in Europe for JH14
  • Somatovac® Vaccine
  • Elanco Inks Agreement to Take Over Lohmann

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 102 (including Divisions/Subsidiaries 123)

  • The United States (23)
  • Canada (2)
  • Japan (6)
  • Europe (41)
  • - France (7)
  • - Germany (7)
  • - The United Kingdom (6)
  • - Italy (3)
  • - Spain (4)
  • - Rest of Europe (14)
  • Asia-Pacific (Excluding Japan) (33)
  • Latin America (10)
  • Middle-East (3)
  • Africa (5)

For more information visit http://www.researchandmarkets.com/research/mv5zz4/veterinary

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.